231 related articles for article (PubMed ID: 28832681)
1. The MHC class II antigen presentation pathway in human monocytes differs by subset and is regulated by cytokines.
Lee J; Tam H; Adler L; Ilstad-Minnihan A; Macaubas C; Mellins ED
PLoS One; 2017; 12(8):e0183594. PubMed ID: 28832681
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the class II MHC pathway in primary human monocytes by granulocyte-macrophage colony-stimulating factor.
Hornell TM; Beresford GW; Bushey A; Boss JM; Mellins ED
J Immunol; 2003 Sep; 171(5):2374-83. PubMed ID: 12928384
[TBL] [Abstract][Full Text] [Related]
3. Synergism of glucocorticoids with granulocyte macrophage colony stimulating factor (GM-CSF) but not interferon gamma (IFN-gamma) or interleukin-4 (IL-4) on induction of HLA class II expression on human monocytes.
Sadeghi R; Hawrylowicz CM; Chernajovsky Y; Feldmann M
Cytokine; 1992 Jul; 4(4):287-97. PubMed ID: 1515553
[TBL] [Abstract][Full Text] [Related]
4. The MHC Class II Antigen-Processing and Presentation Pathway Is Dysregulated in Type 1 Diabetes.
Gilles A; Hu L; Virdis F; Sant'Angelo DB; Dimitrova N; Hedrick JA; Denzin LK
J Immunol; 2023 Dec; 211(11):1630-1642. PubMed ID: 37811896
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of major histocompatibility complex class Ia, Ib, and II molecules on monocytes-derived dendritic and macrophagic cells.
Laupéze B; Fardel O; Onno M; Bertho N; Drénou B; Fauchet R; Amiot L
Hum Immunol; 1999 Jul; 60(7):591-7. PubMed ID: 10426276
[TBL] [Abstract][Full Text] [Related]
6. Cytokines in chronic inflammatory arthritis. IV. Granulocyte/macrophage colony-stimulating factor-mediated induction of class II MHC antigen on human monocytes: a possible role in rheumatoid arthritis.
Alvaro-Gracia JM; Zvaifler NJ; Firestein GS
J Exp Med; 1989 Sep; 170(3):865-75. PubMed ID: 2504878
[TBL] [Abstract][Full Text] [Related]
7. HLA-DO transduced in human monocyte-derived dendritic cells modulates MHC class II antigen processing.
Bellemare-Pelletier A; Tremblay J; Beaulieu S; Boulassel MR; Routy JP; Massie B; Lapointe R; Thibodeau J
J Leukoc Biol; 2005 Jul; 78(1):95-105. PubMed ID: 15817706
[TBL] [Abstract][Full Text] [Related]
8. IL-4 decreases the expression of the monocyte differentiation marker CD14, paralleled by an increasing accessory potency.
Ruppert J; Friedrichs D; Xu H; Peters JH
Immunobiology; 1991 Aug; 182(5):449-64. PubMed ID: 1717365
[TBL] [Abstract][Full Text] [Related]
9. The CLIP-substituted invariant chain efficiently targets an antigenic peptide to HLA class II pathway in L cells.
Fujii S; Senju S; Chen YZ; Ando M; Matsushita S; Nishimura Y
Hum Immunol; 1998 Oct; 59(10):607-14. PubMed ID: 9757942
[TBL] [Abstract][Full Text] [Related]
10. Class II-associated invariant chain peptide expression on myeloid leukemic blasts predicts poor clinical outcome.
Chamuleau ME; Souwer Y; Van Ham SM; Zevenbergen A; Westers TM; Berkhof J; Meijer CJ; van de Loosdrecht AA; Ossenkoppele GJ
Cancer Res; 2004 Aug; 64(16):5546-50. PubMed ID: 15313888
[TBL] [Abstract][Full Text] [Related]
11. 1,25-Dihydroxyvitamin D3 exerts opposing effects to IL-4 on MHC class-II antigen expression, accessory activity, and phagocytosis of human monocytes.
Xu H; Soruri A; Gieseler RK; Peters JH
Scand J Immunol; 1993 Dec; 38(6):535-40. PubMed ID: 8256111
[TBL] [Abstract][Full Text] [Related]
12. HLA-DO increases bacterial superantigen binding to human MHC molecules by inhibiting dissociation of class II-associated invariant chain peptides.
Pezeshki AM; Azar GA; Mourad W; Routy JP; Boulassel MR; Denzin LK; Thibodeau J
Hum Immunol; 2013 Oct; 74(10):1280-7. PubMed ID: 23756162
[TBL] [Abstract][Full Text] [Related]
13. Expression of MHC class II molecules on human monocytes is regulated independently from each other after phagocytosis of bacteria.
Wuorela M; Jalkanen S; Toivanen P; Granfors K
Scand J Immunol; 1996 Jan; 43(1):39-46. PubMed ID: 8560195
[TBL] [Abstract][Full Text] [Related]
14. Differential up-regulation of HLA-DM, invariant chain, and CD83 on myeloid and plasmacytoid dendritic cells from peripheral blood.
Gómez J; Borràs FE; Singh R; Rajananthanan P; English N; Knight SC; Navarrete CV
Tissue Antigens; 2004 Feb; 63(2):149-57. PubMed ID: 14705986
[TBL] [Abstract][Full Text] [Related]
15. Dromedary camel CD14
Hussen J; Shawaf T; Al-Mubarak AIA; Al Humam NA; Almathen F; Schuberth HJ
BMC Vet Res; 2020 Feb; 16(1):62. PubMed ID: 32070351
[TBL] [Abstract][Full Text] [Related]
16. Variation in HLA-DM expression influences conversion of MHC class II alpha beta:class II-associated invariant chain peptide complexes to mature peptide-bound class II alpha beta dimers in a normal B cell line.
Ramachandra L; Kovats S; Eastman S; Rudensky AY
J Immunol; 1996 Mar; 156(6):2196 - 2204. PubMed ID: 8690909
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of HLA-DQ and HLA-DR on cells of the monocytic lineage in cystic fibrosis.
Hofer TP; Frankenberger M; Heimbeck I; Burggraf D; Wjst M; Wright AK; Kerscher M; Nährig S; Huber RM; Fischer R; Ziegler-Heitbrock L
J Mol Med (Berl); 2014 Dec; 92(12):1293-304. PubMed ID: 25146850
[TBL] [Abstract][Full Text] [Related]
18. Type 1 diabetes associated HLA-DQ2 and DQ8 molecules are relatively resistant to HLA-DM mediated release of invariant chain-derived CLIP peptides.
Zhou Z; Reyes-Vargas E; Escobar H; Rudd B; Rockwood AL; Delgado JC; He X; Jensen PE
Eur J Immunol; 2016 Apr; 46(4):834-45. PubMed ID: 26707565
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
[TBL] [Abstract][Full Text] [Related]
20. Salmonella inhibits monocyte differentiation into CD11c hi MHC-II hi cells in a MyD88-dependent fashion.
Rydström A; Wick MJ
J Leukoc Biol; 2010 May; 87(5):823-32. PubMed ID: 20124491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
